19 studies found for:    "Schizophrenia, Paranoid"
Show Display Options
Rank Status Study
1 Unknown  Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection
2 Completed Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Interventions: Drug: asenapine;   Drug: placebo BID
3 Completed Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM2 EXT)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Intervention: Drug: asenapine
4 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)(COMPLETED)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)
5 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)
6 Completed A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
Conditions: Schizophrenia;   Mania;   Delusional Disorder;   Acute Exacerbation of Psychosis
Intervention: Drug: Ziprasidone
7 Recruiting Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention:
8 Terminated Schizophrenic Patients Taking Part in Integrated Care Program
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreni-form Disorder;   Delusional Disorder;   Psychotic Disorder Not Otherwise Specified
Intervention:
9 Unknown  Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
Conditions: Psychotic Disorders;   Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder;   Schizophreniform Disorder
Intervention: Behavioral: modified cognitive behavioural therapy (mCBT)
10 Recruiting Integrated Care in Psychosis
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Delusional Disorder;   Psychotic Disorder NOS;   Bipolar Disorder;   Severe Major Depression With Psychotic Features
Intervention: Other: Integrated care
11 Completed Acceptance and Commitment Therapy for Delusions
Conditions: Schizophrenia;   Delusional Disorder
Intervention: Behavioral: Acceptance and Commitment Therapy
12 Recruiting Improving Work Outcome for People With Severe Mental Illness
Conditions: Schizophrenia, Schizotypal and Delusional Disorders;   Bipolar Affective Disorder;   Recurrent Depressive Disorder
Interventions: Behavioral: Individual Placement and support (IPS);   Behavioral: IPS plus
13 Unknown  Trial of Cognitive Behavioral Therapy for Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention: Behavioral: Cognitive Behavioral Therapy
14 Recruiting Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorder
Intervention: Drug: Risperidone/Olanzapine and PET scans
15 Unknown  Cognitive Determinants of Psychoeducation and Information in Psychoses
Conditions: Schizophrenia;   Delusional Disorders (ICD-10)
Intervention: Behavioral: COGPACK training, psychoeducation
16 Terminated Anticholinergic Burden in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorders
Intervention: Drug: Benztropine
17 Active, not recruiting Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychosis
Intervention: Behavioral: Multi-element, team-oriented treatment
18 Unknown  Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Behavioral: Cognitive Behavioral Therapy
19 Completed Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
Condition: Schizophrenia
Interventions: Device: t-VNS verum;   Device: t-VNS placebo

Indicates status has not been verified in more than two years